# OnCo record car-t-infection-prevention (protocol). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/protocols/car-t-infection-prevention/>
  a schema:MedicalGuideline ;
  onco:kind "protocol" ;
  schema:identifier "car-t-infection-prevention" ;
  schema:name "Infection screening, prophylaxis and immunoglobulin replacement around CAR T-cell therapy"@en ;
  schema:alternateName "CAR-T antimicrobial prophylaxis"@en, "CAR T infection prevention"@en, "IVIG after CAR T"@en, "hypogammaglobulinaemia after CAR T"@en, "PJP prophylaxis CAR T"@en ;
  schema:description "Infections are the commonest serious problem in the months after CAR T-cell therapy. You are first tested for hepatitis B, HIV and other viruses. Afterwards most centres give tablets against shingles, cold sores and a type of pneumonia for at least six months, check antibody levels, and may give antibody infusions if they are low and infections recur. Any fever needs a call to the team at once."@en ;
  schema:url <https://onco.cc/protocols/car-t-infection-prevention/> ;
  schema:dateModified "2026-11-11"^^xsd:date ;
  onco:tag "protocol", "cell-therapy", "car-t", "infection" ;
  onco:related <https://onco.cc/protocols/crs-grading-and-management/>, <https://onco.cc/protocols/icans-grading-and-management/>, <https://onco.cc/protocols/bispecific-step-up-dosing/> ;
  onco:technologies <https://onco.cc/technologies/car-t/> ;
  onco:drugs <https://onco.cc/drugs/human-normal-immunoglobulin/>, <https://onco.cc/drugs/axicabtagene-ciloleucel/>, <https://onco.cc/drugs/tisagenlecleucel/>, <https://onco.cc/drugs/lisocabtagene-maraleucel/>, <https://onco.cc/drugs/brexucabtagene-autoleucel/>, <https://onco.cc/drugs/idecabtagene-vicleucel/>, <https://onco.cc/drugs/ciltacabtagene-autoleucel/>, <https://onco.cc/drugs/obecabtagene-autoleucel/> ;
  onco:terms <https://onco.cc/terms/lymphoma-tx-immunoglobulin-replacement/>, <https://onco.cc/terms/hbv-hcv/> .